Environmental risk analysis and prioritization of pharmaceuticals in a developing world context
- 1 July 2016
- journal article
- Published by Elsevier in Science of The Total Environment
- Vol. 557-558, 31-43
Abstract
No abstract availableKeywords
Funding Information
- American University of Beirut (URB-102544)
This publication has 50 references indexed in Scilit:
- Improving Environmental Risk Assessment of Human PharmaceuticalsEnvironmental Science & Technology, 2015
- An integrated approach for prioritizing pharmaceuticals found in the environment for risk assessment, monitoring and advanced researchChemosphere, 2014
- Prioritising anticancer drugs for environmental monitoring and risk assessment purposesScience of The Total Environment, 2014
- Pharmaceuticals and Personal Care Products in the Environment: What Are the Big Questions?Environmental Health Perspectives, 2012
- Highly active human pharmaceuticals in aquatic systems: A concept for their identification based on their mode of actionAquatic Toxicology, 2010
- Exposure Assessment of Pharmaceuticals and Their Metabolites in the Aquatic Environment: Application to the French Situation and Preliminary PrioritizationHuman and Ecological Risk Assessment: An International Journal, 2008
- Preliminary risk assessment database and risk ranking of pharmaceuticals in the environmentScience of The Total Environment, 2008
- Are pharmaceuticals potent environmental pollutants?Science of The Total Environment, 2006
- Removal of Pharmaceuticals in Sewage Treatment Plants in ItalyEnvironmental Science & Technology, 2005
- Investigating the environmental transport of human pharmaceuticals to streams in the United KingdomScience of The Total Environment, 2004